Natera to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA testing, has announced that CEO Steve Chapman and CFO Mike Brophy will present at two upcoming investor conferences. The first is the Morgan Stanley Global Healthcare Conference on Sept. 13, 2022, at 4:05 pm ET, followed by the Baird 2022 Global Healthcare Conference on Sept. 14, 2022, at 2:00 pm ET. Live and archived webcasts will be accessible on the Natera Investor Relations website.

AUSTIN, Texas, Sept. 6, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that Steve Chapman, chief executive officer, and Mike Brophy, chief financial officer, will be presenting at the following upcoming investor conferences:

• Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 13 at 4:05 pm ET.
• Baird 2022 Global Healthcare Conference on Wednesday, Sept. 14 at 2:00 pm ET.

Interested parties may access live and archived webcasts of the presentation on the Natera Investor Relations website at investor.natera.com, where the webcasts will be archived for future reference.

About Natera

Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that help lead to longer, healthier lives. Natera's tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

Forward-Looking Statements

All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera's plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera's expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera's recent filings on Forms 10-K and 10-Q and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Brian Symmons, SVP of Marketing and Corporate Affairs, Natera, Inc., pr@natera.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/natera-to-participate-in-upcoming-investor-conferences-301618476.html

SOURCE Natera, Inc.

FAQ

When is Natera presenting at the Morgan Stanley Global Healthcare Conference?

Natera will present at the Morgan Stanley Global Healthcare Conference on September 13, 2022, at 4:05 pm ET.

What date will Natera present at the Baird 2022 Global Healthcare Conference?

Natera will present at the Baird 2022 Global Healthcare Conference on September 14, 2022, at 2:00 pm ET.

Who from Natera will be speaking at the investor conferences?

CEO Steve Chapman and CFO Mike Brophy will be representing Natera at the investor conferences.

Where can I find the webcasts for Natera's investor presentations?

You can access live and archived webcasts of Natera's presentations on their Investor Relations website.

What is Natera known for?

Natera is known as a global leader in cell-free DNA testing, focusing on oncology, women's health, and organ health.